Brian Joseph Cahill
CIK 1831591 · CHIEF FINANCIAL OFFICER · last filed 2024-02-29
Brian Joseph Cahill is a CHIEF FINANCIAL OFFICER who has filed 20 SEC Form 4 insider transactions across 1 company since 2021. The most recent filing, for EGRX, was dated Feb 29, 2024.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
1
20
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted | CHIEF FINANCIAL OFFICER | 47,958 | $2.14 | $102.6K | $0 | 20 | 2024-02-29 |
Recent Filings
20 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-02-29 | EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted | Mixed | +2,211 | -$10.2K | EDGAR |
| 2024-02-06 | EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted | Tax (F) | −934 | -$5.5K | EDGAR |
| 2024-01-09 | EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted | Tax (F) | −735 | -$3.8K | EDGAR |
| 2023-12-20 | EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted | Tax (F) | −452 | -$2.2K | EDGAR |
| 2023-03-02 | EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted | Mixed | +17,782 | -$20.1K | EDGAR |
| 2023-02-06 | EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted | Tax (F) | −785 | -$26.8K | EDGAR |
| 2023-01-31 | EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted | Tax (F) | −601 | -$20.0K | EDGAR |
| 2023-01-09 | EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted | Tax (F) | −734 | -$21.5K | EDGAR |
| 2022-12-21 | EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted | Tax (F) | −461 | -$13.8K | EDGAR |
| 2022-03-02 | EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted | Grant (A) | +8,000 | $0 | EDGAR |